Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 19 open reading frame 48, pseudogene (C19orf48P) is designated as a pseudogene in the human genome and is not believed to encode an active protein product[3][5]. While some database annotations reference "multidrug resistance-related protein," there is no validated evidence that this locus produces a member of the ATP-binding cassette (ABC) transporter family or confers drug resistance activity[5]. The gene is predicted, based on computational analysis, to be involved in RNA processing and possibly to be localized to the nucleolus, but functional validation and protein expression are lacking[2][3]. Pseudogenes like C19orf48P may arise from duplication or mutation of protein-coding genes but are typically transcriptionally inactive or do not encode a functional protein. Despite gene-disease association database entries linking this locus to certain tumors (parathyroid adenoma, ovarian cancer), these are associative and lack evidence for a mechanistic or therapeutic target role[3]. The gene is neither a validated receptor, transporter, enzyme, nor a practical therapeutic target. Key clarification: - The label "multidrug resistance-related protein" is likely a misannotation—there is no evidence that C19orf48P encodes any such protein. Multiple authoritative sources affirm its pseudogene status and lack of molecular function[3][5][2]. - The true multidrug resistance proteins (e.g., MRP1/ABCC1, MRP2/ABCC2, P-glycoprotein/ABCB1, BCRP/ABCG2) are well characterized membrane proteins and are distinct from this locus[1]. If information about multidrug resistance-related proteins (MRP/ABCC family transporters) is actually intended, a different and specific gene locus (such as ABCC1 or ABCC2) should be referenced.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 19 open reading frame 48, pseudogene (C19orf48P).